テストステロン補充療法の市場規模、シェア、成長分析、製品タイプ別、有効成分別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

テストステロン補充療法の世界市場規模は、2022年に約14億米ドルと評価され、予測期間（2024-2031年）のCAGRは8.9%で、2023年の15億米ドルから上昇し、2031年には29億米ドルに達すると予測されています。

世界のテストステロン補充療法（TRT）市場は、高齢化、ライフスタイルの変化、ストレスレベルの上昇など、テストステロン欠乏症増加の原因となる要因が重なり、大きな成長を遂げています。TRTは、テストステロンレベル低下の正確な診断と管理に不可欠な診断テストやモニタリング装置とともに、注射、ジェル、パッチ、ペレットなど、さまざまな製品や治療方法を包含しています。テストステロンの生産は加齢とともに自然に減少するため、効果的な治療オプションに対するニーズが高まることになり、高齢化層が主要な推進力となっています。さらに、ヘルスケア専門家は、欠乏を診断し、適切な治療を処方し、患者の安全性と治療効果を確保することで、この市場で重要な役割を果たしています。製薬会社やクリニックが主導する継続的な研究開発努力により、市場は新しく革新的なTRTソリューションを導入するために進化しています。この成長傾向は米国市場で顕著であり、今後数年間は持続的な年間平均成長率（CAGR）を維持すると予測されています。テストステロン補充療法の需要が高まり続ける中、同市場は、欠乏症を経験する人々の生活の質を向上させるという位置づけにあり、より広範な医薬品・医療分野における重要性を示しています。全体として、TRT市場は、進化する人口のヘルスケアニーズに対応しようとする中で、ますます重要性を増しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 規制分析
• ケーススタディ分析
• 特許分析
• 価格分析

テストステロン補充療法市場：製品タイプ別

• 市場概要
• 注射
• 外用
• その他

テストステロン補充療法市場：有効成分別

• 市場概要
• テストステロンウンデカン酸
• テストステロンシピオネート
• テストステロン
• テストステロンエナンセート
• その他

テストステロン補充療法市場：エンドユーザー別

• 市場概要
• 病院
• クリニック

テストステロン補充療法市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• AbbVie Inc.
• Pfizer Inc.
• Endo International plc
• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• Acerus Pharmaceuticals Corporation
• Marius Pharmaceuticals
• Insud Pharma S.L.
• Allergan
• Hikma Pharmaceuticals PLC
• Cipla Inc.
• Sun Pharmaceutical Industries Ltd.
• Lupin Pharmaceuticals
• Novartis AG
• AstraZeneca

Global Testosterone Replacement Therapy Market size was valued at around USD 1.4 billion in 2022 and is expected to rise from USD 1.5 billion in 2023 to reach a value of USD 2.9 billion by 2031, at a CAGR of 8.9% over the forecast period (2024-2031).

The Global Testosterone Replacement Therapy (TRT) market is experiencing significant growth, driven by a confluence of factors including an aging population, lifestyle changes, and an increase in stress levels, which have all contributed to rising testosterone deficiencies. TRT encompasses a range of products and treatment modalities such as injections, gels, patches, and pellets, alongside diagnostic tests and monitoring devices essential for accurate diagnosis and management of low testosterone levels. The aging demographic is a key driver, as testosterone production naturally declines with age, leading to a greater need for effective therapy options. Additionally, healthcare professionals play a crucial role in this market by diagnosing deficiencies, prescribing suitable treatments, and ensuring patient safety and treatment efficacy. With ongoing research and development efforts spearheaded by pharmaceutical companies and clinics, the market is evolving to introduce new and innovative TRT solutions. This growth trend is underscored in the US market, which is projected to maintain a sustainable compound annual growth rate (CAGR) in the upcoming years. As the demand for testosterone replacement therapy continues to rise, the market is positioned to enhance the quality of life for individuals experiencing deficiencies, marking its significance within the broader pharmaceutical and medical sectors. Overall, the TRT market is becoming increasingly vital as it seeks to address the healthcare needs of an evolving population.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Testosterone Replacement Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Testosterone Replacement Therapy Market Segmental Analysis

Global Testosterone Replacement Therapy Market is segmented by Product Type, Active ingredients, End User, and region. Based on Product Type, the market is segmented into Injectables, Topical, and Others. Based on Active ingredients, the market is segmented into Testosterone Undecanoate, Testosterone Cypionate, Testosterone, Testosterone Enanthate, and Others. Based on End User, the market is segmented into Hospitals, Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Testosterone Replacement Therapy Market

The growing prevalence of testosterone insufficiency, especially among males aged 40 to 79, is a significant market driver for the global testosterone replacement therapy (TRT) market. With approximately 20% of men over 60 and 30% over 70 experiencing low testosterone levels, combined with an estimated 10% to 40% of the global male population affected by this condition, the demand for effective TRT solutions is surging. Additionally, the upward trajectory of the elderly demographic further compounds this need, creating increased awareness and acceptance of TRT as a viable treatment option, thereby propelling market growth and innovation in therapeutic offerings.

Restraints in the Global Testosterone Replacement Therapy Market

The global testosterone replacement therapy market faces significant restraints due to the substantial risk of various post-treatment complications, including sleep apnea, acne, gynecomastia, and heightened risk of thromboembolic events. These potential side effects deter patients and healthcare providers from pursuing treatment, thereby inhibiting market growth. Additionally, the high costs associated with testosterone therapy, coupled with the need for ongoing medical supervision and potential follow-up treatments, further limits accessibility for patients. These combined factors contribute to hesitance among both consumers and practitioners, ultimately stifling the demand and expansion of the testosterone replacement therapy market on a global scale.

Market Trends of the Global Testosterone Replacement Therapy Market

The global testosterone replacement therapy (TRT) market is experiencing a notable shift towards personalized treatment options, catering to individual patient needs. This trend has spurred the growth of compounding pharmacies that offer customizable formulations. In tandem, pharmaceutical companies are innovating delivery methods, introducing products like nasal sprays and transdermal patches to enhance treatment convenience and efficacy. Additionally, an integrated approach combining TRT with lifestyle changes is gaining traction, advocating for holistic hormone management. The rise of digital health technologies further transforms the market, with telemedicine facilitating remote consultations, while mobile apps monitor hormone levels, ultimately improving patient access and engagement in their TRT journey.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Case Study Analysis
• Patent Analysis
• Pricing Analysis

Testosterone Replacement Therapy Market, By Product Type

• Market Overview
• Injectables
• Topical
• Others

Testosterone Replacement Therapy Market, By Active ingredients

• Market Overview
• Testosterone Undecanoate
• Testosterone Cypionate
• Testosterone
• Testosterone Enanthate
• Others

Testosterone Replacement Therapy Market, By End User

• Market Overview
• Hospital
• Clinics

Testosterone Replacement Therapy Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acerus Pharmaceuticals Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marius Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insud Pharma S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments